121.82
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Repligen Corp | RGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 121.82 | 0.00 | 0.00 | 0.00 | 121.82 | 04:04:36 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 117.62 | 127.00 | 9.38 | 7.39% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 121.82 | USD |
Repligen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 6.37B | 52.31M | 49.76M | $ 270.25M | $ 21.92M | 0.44 | 287.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 21.00 | 4.90% |
Repligen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 130.04 | 135.40 | 120.72 | 129.22 | 654,701 | -8.22 | -6.32% |
| 1 Month | 123.84 | 143.93 | 120.72 | 131.87 | 550,692 | -2.02 | -1.63% |
| 3 Months | 92.92 | 159.62 | 78.41 | 110.70 | 569,603 | 28.90 | 31.1% |
| 6 Months | 89.02 | 159.62 | 78.41 | 103.29 | 500,909 | 32.80 | 36.85% |
| 1 Year | 74.39 | 159.62 | 72.32 | 93.29 | 531,251 | 47.43 | 63.76% |
| 3 Years | 40.05 | 159.62 | 29.56 | 68.47 | 410,023 | 81.77 | 204.17% |
| 5 Years | 38.29 | 159.62 | 20.07 | 57.03 | 352,854 | 83.53 | 218.15% |
Repligen Description
| Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States. |
